neXendo Wellness

neXendo Wellness operates as a telehealth-focused endocrinology and weight management clinic serving patients across New York from its Long Island City base. The practice centers on evidence-based medical weight loss protocols that integrate endocrine evaluation, nutritional counseling, and physician-supervised peptide therapy. With a 4.9-star rating across 675 patient reviews, neXendo has built its reputation on thorough metabolic assessments and accessible virtual care that eliminates the barriers of traditional in-office visits for patients managing obesity, prediabetes, and metabolic syndrome.

The clinic's peptide therapy program features tirzepatide and semaglutide, both GLP-1 receptor agonists proven to regulate appetite, improve insulin sensitivity, and support significant weight reduction when combined with lifestyle modification. Tirzepatide, a dual GIP/GLP-1 agonist, offers enhanced metabolic benefits for patients who require more aggressive intervention for type 2 diabetes management alongside weight loss. Semaglutide provides once-weekly dosing convenience and has demonstrated sustained weight loss outcomes in clinical populations. neXendo's endocrinologists prescribe these peptides following comprehensive metabolic panels, hemoglobin A1c testing, and thyroid function assessments to ensure appropriate candidacy and to monitor patient response throughout treatment. The practice does not offer one-size-fits-all protocols; dosing is titrated based on individual tolerance, weight loss velocity, and metabolic markers tracked through regular blood work.

The clinical team includes board-certified endocrinologists and registered nurses who conduct virtual consultations, review lab results, and adjust treatment plans through the telehealth platform. Patients report that the endocrinologists take time to explain the mechanisms of GLP-1 therapy, discuss realistic expectations for weight loss timelines, and address concerns about side effects such as nausea or gastrointestinal adjustment periods. The nursing staff coordinates prescription fulfillment, insurance verification, and follow-up scheduling, ensuring continuity between monthly check-ins. This collaborative model allows patients to receive endocrine-level care without the logistical challenges of commuting into Long Island City, making the practice accessible to working professionals and patients with mobility limitations across the New York metropolitan area.

Patients beginning treatment at neXendo Wellness can expect an initial telehealth consultation that includes a detailed medical history review, discussion of previous weight loss attempts, and evaluation of comorbid conditions such as hypertension, sleep apnea, or polycystic ovary syndrome. The endocrinologist will order baseline labs—typically a comprehensive metabolic panel, lipid profile, thyroid panel, and A1c—which patients complete at a local lab before starting peptide therapy. Once results are reviewed and a treatment plan is established, prescriptions are sent to specialty pharmacies, and patients receive instruction on subcutaneous injection technique, dosage escalation schedules, and dietary modifications that enhance peptide efficacy. Monthly follow-ups track weight trends, review any side effects, and determine whether dose adjustments are warranted. The practice emphasizes that peptide therapy is most effective when paired with nutritional guidance, and many patients work concurrently with the clinic's nutrition team to address caloric intake, macronutrient balance, and behavioral eating patterns.

neXendo Wellness differentiates itself through its exclusive telehealth model, which has proven particularly effective for patients managing chronic conditions that require ongoing monitoring but not frequent in-person visits. The virtual format allows for flexible appointment scheduling, often with same-week availability, and eliminates travel time for patients across Long Island, the boroughs, and surrounding counties. The practice accepts most major insurance plans for endocrinology consultations and lab work, though patients should verify coverage for GLP-1 peptides, as insurance authorization varies by plan and medical necessity criteria. For self-pay patients, the clinic provides transparent pricing for consultations and works with compounding pharmacies to offer cost-effective peptide options when brand-name formulations are prohibitively expensive. This combination of clinical rigor, accessible telehealth delivery, and insurance navigation support has made neXendo a high-volume practice for New Yorkers seeking medically supervised weight loss with endocrine expertise.